PROTEIN ASSAYS MARKET ANALYSIS

Protein Assays Market, By Product Type (Reagents and Kits and Accessories), By Technology Type (Absorbance based Protein Assays, Colorimetric Protein Assays, and Fluorescence based Protein Assays), By End User (Pharmaceutical and Biotechnology Industry Clinical Laboratories, Hospitals, Academic Research Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In June 2024, Sysmex Corporation announced the upcoming launch of the HISCL VEGF and HISCL PEDF Assay Kits for Research Use in Japan. These research reagents, designed for measuring secreted proteins in cell culture media, aim to enhance automation and efficiency in quality control testing for regenerative cellular medicine.
In June 2023, Pixelgen Technologies, a leader in single-cell spatial proteomics, announced the commercial release of its inaugural kit. This kit utilizes the company’s proprietary Molecular Pixelation (MPX) technology for three-dimensional spatial analysis of immune cell surface proteins.
In May 2023, 10x Genomics, Inc., a pioneer in single-cell and spatial biology, announced the commercial release of its new VisiumCytAssist Gene and Protein Expression product. This addition enhances the capabilities of the VisiumCytAssist for spatial analysis.
In March 2022, Biognosys introduced an enhanced range of proteomics platforms designed to offer pharmaceutical and diagnostics clients profound biological insights throughout the entire R&D pipeline, from initial discovery stages to clinical applications.
In January 2022, Amgen formed a partnership with Generate Biomedicines to discover and develop protein therapeutics targeting five different areas across various therapeutic fields and modalities, with an initial investment exceeding USD 1.9 billion